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Abstract
Urinary stone disease is a common, often recurrent disease, that can have a negative impact on patients’ health-related 
quality of life (HRQoL), often effecting working, productive members of society. The literature lacks data from structured, 
qualitative research which could give unique insight into patients’ HRQoL. The objective is to understand the impact of 
urinary stone disease and treatments on patients’ HRQoL, from patients’ and their relatives’ perspective using qualitative 
and quantitative methodologies. Semi-structured interviews and a focus group were used to understand the HRQoL issues of 
patients with urinary stones disease, covering the American Urology Association index stone categories. Thematic analysis 
was performed (using qualitative data analysis software). Familial impact was assessed using the family-related outcome 
measure (FROM-16©). 62 patients with stone disease and interventions (mean age 51, range 19–92) participated. Data col-
lection stopped when data saturation was achieved. Analysis revealed negative impact of stone disease and interventions on 
the patients’ HRQoL, affecting domains of pain, physical symptoms, outlook on life, work/career, change in lifestyle/diet, 
social life, difficulties of daily living, travel/holiday problems, relationships and family member impact (106 themes grouped 
under ten broad headings). Sub-group analyses revealed similar impact in either sex, ureteric and renal stone groups. Recur-
rent stones were associated with work/financial concerns and treatment preferences varied accordingly. Our qualitative study 
presents detailed insights into the multidimensional impact of urinary calculi and their treatments on various domains of the 
HRQoL, confirming previous findings and adding new observations. The findings are expected to help in the development 
of patient-centric measures and communication tools.
Keywords Urinary stone disease · Urolithiasis · Renal stones · Ureteric stones · Quality of life · Basic research · Patient-
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Introduction
The prevalence of urinary stone disease is high and is esti-
mated to be 2–3% amongst the general population. The dis-
ease is a common cause for emergency hospital admissions 
with over 30,800 hospital admissions reported in England 
annually and 550,000 emergency room visits in the US 
in 2009 [1, 2]. The peak age of incidence is between 35 
and 55 years. The recent evidence suggests that in west-
ern nations the incidence of renal stones has increased and 
women might be nearly as affected as men [3–5]. Risk of 
recurrence is estimated to be 50% within 5 years of the first 
stone episode. Given their age, patients with urinary stone 
disease are often working, productive members of society 
and if they require a leave of absence from employment, it 
could have economic ramifications on the individual, their 
family and on a wider, societal level [6].
Urinary stones present with a myriad of clinical features 
ranging from the pain of acute ureteric colic and systemic 
sepsis to minimal or asymptomatic disease. Once emergency 
treatment has been completed (treatment of infection, acute 
kidney injury and amelioration of pain), definitive treatment 
must be planned. This treatment pathway can be complex, 
multi-staged and can involve multiple hospital visits and 
admissions. Many patients suffer with recurrent/multiple 
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stones requiring ongoing treatments. Stone disease and its 
treatment(s) can have an adverse effect on patients’ health-
related quality of life (HRQoL) [7–12].
Various interventional treatments (shock wave lithotripsy 
and ureteroscopy) and non-interventional treatments exist, 
including expectant treatments. Patients with larger renal 
stones have the option of percutaneous nephrolithotomy 
(PNCL) and additional treatment options [13]. The treat-
ment pathways’ success rates, as well as risks, are different 
with each treatment route.
The current pathway of care is suboptimal, considering 
the need to incorporate patient-reported outcomes, patient 
treatment preferences and resource efficiency. Most of the 
evidence is focused on the limited aspects of clinical man-
agement. In spite of clear indications from the literature for 
the need to understand patient perspectives in a scientific 
way on patients’ HRQoL (including the impact of disease 
and interventions), very few research groups have published 
peer-reviewed papers in this field [7–12]. This has made it 
difficult to evaluate and compare different treatments and 
technologies effectively. Many aspects of the treatments 
could be changed and traded if patient perspectives could 
be better understood. Currently, this results in the treatments 
being offered on an ad hoc basis, with patients being inad-
equately informed, while often putting them through pro-
tracted treatment journeys. There are also economic implica-
tions for possible inefficient use of resources.
Patient-reported outcome measures attempt to quan-
tify patients’ health-related quality of life in a valid and 
reproducible way. Patients’ expectations of treatment and 
the impact of disease and their treatments on HRQoL are 
important outcome parameters. AUA guidelines on the treat-
ment of urinary calculi state that treatment decisions should 
incorporate patient preferences to treatments, which would 
be influenced by quality of life [14]. Generic measures such 
as the SF-36 and the EQ-5D have been used to measure 
HRQoL but these measures tend to evaluate narrow aspects 
of the impact and often fail to elaborate on the clinically rele-
vant domains. The impact of urinary calculi has been studied 
in more detail (using predominantly quantitative methods), 
in the recent years. These studies include Wisconsin Quality 
of Life (WISQOL), as well as questionnaires using the items 
from the PROMIS (Patient Reported Outcomes Information 
System) question bank in acute or chronic stages of stone 
disease [8, 11]. It has been suggested that the best treatment 
decisions are made when tailored to the needs and choices 
of individual patients [15, 16]. Qualitative research offers 
detailed understanding of patient views and is an essential 
first step in developing patient-centric measures. Qualitative 
research methods provide an opportunity for a systematic, 
in-depth evaluation of issues that may not be necessarily be 
answered through quantitative methods and are becoming 
increasingly common and valued in medical literature.
The aim of this study was to assess and understand the 
impact of urinary stone disease and treatments on patients’ 
quality of life from the perspective of patients and their fam-
ily members. We expect the results to offer detailed insights 
into stone disease and form the foundations for the develop-
ment of patient-centric measures and tools which will be 
used to facilitate good communication with patients about 




Ethical and scientific approval was gained according to 
local guidelines (IRAS project ID 138478) for the conduct 
of qualitative study involving patient interviews and focus 
group discussion. Informed, written consent was gained and 
recorded. Data were handled in accordance to national data 
regulation guidelines.
Participants
Patients suffering with urinary stone disease from the inpa-
tient and outpatient settings of a university hospital stone 
management unit were invited to participate by a urologist 
with clinical responsibility for part or all of the participants 
care between and April 2014 and July 2016.
A list of inclusion and exclusion criteria is provided in 
Table 1. Patients were purposefully selected based on the 
nature of their disease to cover most of the index catego-
ries of stone disease. The groups sampled included those 
with renal or ureteric stones, symptomatic or asymptomatic 
disease with or without prior treatment. No payment was 
received for participation in this study, but travel expenses 
were offered. In addition, family members of 30 patients 
who were identified as next of kin, and attended with a 
patient, were invited to complete a family-reported outcome 
measure (FROM) questionnaire [20] in relation to their rela-
tive’s stone disease on a sequential basis, mostly in the clinic 
setting. The relative’s clinical status did not have a bearing 
on their inclusion/exclusion of the study.
Table 1  Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Adult patients (18 years upward) Unable to give informed consent
Past or present urinary stone 
disease
Unable to speak English fluently




Patients participated in semi-structured interviews lasting 
between 30 and 90 min with a urology clinical research fel-
low trained in qualitative research methods. All interviews 
and the focus group took place in a quiet room in Urology 
outpatient department of the hospital or at patient’s houses. 
The interview schedule for the semi-structured interviews 
was created using the expert opinion of local urologists. 
Patients were encouraged to speak freely about acute and 
chronic health-related quality of life issues that they experi-
ence or have experienced due to their stone disease or its 
treatment. One focus group of eight participants was carried 
out as a consensus exercise.
Qualitative thematic analysis
Interviews were digitally recorded, transcribed and the-
matic analysis was performed supported by qualitative data 
analysis software (NVivo 10 for Mac) in line with recom-
mendations [21]. The stages of thematic analysis are seen 
in Table 2.
Transcripts were examined to identify key themes and 
coded by a single researcher. Interviews continued in each 
group, until saturation was reached and no new themes 
emerged, as is the current standard in qualitative data anal-
ysis in health settings [22–24]. Ten percent of interviews 
were analysed by a second coder to ensure consistency and 
quality assurance [25]. Key themes were tabulated and those 
mentioned by three or more patients were considered com-
mon. Common key themes were converted into questions 
and consolidated under broad headings. These broad head-
ings were then grouped into overall domains.
Family‑related outcome measure (FROM‑16©)
The FROM-16© questionnaire is a generic, validated tool 
used to assess the effect a patient’s disease has on a family 
member in two domains—‘emotional’ and ‘personal and 
social life’ [20]. FROM-16© was completed by a patient’s 
relative either in the clinic or inpatient setting.
Results
Seventy-four patients were invited to participate. Sixty-two 
patients took part in interviews with a mean age of 51 (range 
19–92). Ten patients declined, with reasons stated being 
‘not interested’ and ‘lack of time’. Eight patients (five had 
taken part in the interviews, three had not) participated in 
a consensus focus group and no new themes were elicited 
during the process. Four patients were asymptomatic at the 
time of interview and 58 were symptomatic. Twenty-one 
participants were female (33%) and 41 male (67%). Twenty 
were first-time stone formers (32%) and 42 recurrent stone 
formers (68%). Three patients suffered with cystinuria (5%) 
and one patient had the diagnosis of distal renal tubular aci-
dosis (2%).
Themes
From the interviews, 106 themes were generated. These 
were grouped together under 10 broad headings (Table 3) 
and within three overall domains; ‘physical’, ‘psychosocial’ 
and ‘other’.
Within the broad heading of ‘physical symptoms other 
than pain’ nausea and vomiting, frequency/urgency of urine 
and haematuria were the most commonly reported quality-
of-life issues. Under the broad category of ‘pain’, acute and 
intense pain was the by far the most common hindrance to 
good quality of life with intermittent/chronic pain com-
ing second. Within the ‘outlook on life’ theme, fear of the 
Table 2  Thematic analysis 
process [21] 1. Key themes or ‘big ideas’ identified following reading and re-reading the interview transcripts
2. ‘Units of information’ identified and highlighted (sentences/phrases) relevant to the research purposes
3. Selection of category headings to sort and group ‘units of information’
4. ‘Units of information’ coded into category headings to enable units to be placed within a category
5. Negotiation between research team members to the headings that most economically accommodate 
‘units of information’
6. Categories generated in the first phase of data analysis are reviewed and revised
Table 3  Broad theme headings




Change in lifestyle or diet
Mental and emotional symptoms
Social life
Difficulties with activities of daily living




unknown and the fact that it seemed like ‘there was no end to 
the disease’ were the most common problems. With regard 
to ‘work’, the need to take time off work and the interference 
the disease had on career were most problematic. Loss of 
income is also a common problem encountered (although 
this was seen more in patients that were self-employed). 
Examples of quotes for different broad theme headings are 
seen in Table 4.
Sub‑group analysis
Ureteric vs renal stones
Patients with ureteric stones complained most about prob-
lems with work, particularly needing to take time off work. 
Pain and other physical symptoms were the second most 
problematic quality-of-life issues faced. Patients with renal 
stones at the time of the interview reported that physical 
symptoms other than pain were the worst HRQoL issue 
faced. Outlook on life was the second most reported issue, 
with fear of the unknown being the greatest problem under 
this heading. Pain was the third most common for patients 
with renal disease. However, it was important to note that 
both the groups had similar domains of QoL affected by 
the disease. Similarly, many patients, with recurrent disease 
reported to have experience of both ureteric and renal stones 
over a long period of time and the QoL issues appeared to 
be interlinked.
Age
For the youngest group of patients (younger than 35), 
physical symptoms other than pain were most commonly 
reported, followed by a negative outlook on life. Work was 
the third most important HRQoL issue in this age group 
with the inability to work, loss of income and the fear of 
losing their job being the worst aspects of this problem. For 
patients aged 36–60, physical symptoms other than pain 
and problems with work were most reported, with the need 
to take time off work and the fear of financial stress being 
major HRQoL difficulties. Pain was the third most important 
issue in this age group. Patients aged older than 61 felt the 
most difficult aspects of poor HRQoL were due to pain, other 
physical symptoms and a poor outlook on life.
Recurrent vs first‑time stone formers
There was little difference reported between the HRQoL 
issues faced by recurrent and first-time stone formers. How-
ever, recurrent stone formers were much more concerned 
about the effect their stone disease had on their job/careers, 
with the major concerns being the need to take time of work 
and the financial instability associated with it.
Duration of disease
Patients were split into those suffering with urinary stone 
disease for less than a year, 1–3  years and more than 
4 years. For those patients who had been suffering with 
their disease for less than 1 year and 1–3 years, no differ-
ence was seen in HRQoL problems. However, for those 
who had been suffering for the more than 4 year, the work 
and a negative outlook on life appeared to have a greater 
impact on the HRQoL of patients.
Patient communication and treatment preferences
Fifteen patients felt that they had not been given enough 
information before choosing treatment options in the past 
and six reported getting conflicting advice on treatment 
and stone prevention from different health professional 
(GPs, primary care nurses, emergency room doctors and 
urologists). Eleven patients reported getting information 
from the internet, 3 from their GP, and 15 from the hospi-
tal staff, 7 of whom reported receiving and reading hospi-
tal information sheets.
Patient preferences were varied. Nine patients preferred 
the least painful/invasive treatment and 16 felt they would 
like to avoid an operation/general anaesthetic. Sixteen felt 
they would simply follow the surgeon’s advice.
FROM survey results
Patient’s family members’ scores reflected that they were 
not overly affected by their family members’ disease. Par-
ticipants reported a marginally greater degree of change 
in the ‘emotional’ domain compared to the ‘personal and 
social life’ domain. Participants scored questions regard-
ing ‘being worried and sad’ highest and ‘difficulty with 
eating and travel’ lowest.
Discussion
Our study demonstrates that stone disease and interven-
tions tend to have significant impact on different domains 
of health-related quality of life. We found that there were 
few differences between sub-groups in terms of the qual-
ity-of-life issues faced. Pain along with physical symptoms 
other than pain seems to have the greatest impact on the 
HRQoL of patients and issues regarding work seem to be 
important to all sub-groups. Missing days from work and 
the possible financial instability that may ensue has been 
highlighted by patients throughout the study. This might 
Urolithiasis 
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Table 4  Major themes, sub-themes and example quotes




Physical symptoms: pain 56 “I was curled up in a ball saying I just needed some painkillers, some relief just to 
relieve it”
Patient 007, male 61 single ureteric stone
Outlook on life 53 “It is like a ticking time bomb that is just hovering over you and you are just waiting 
for your next hospital admission…”
Patient 065, female 39, recurrent stone former
Physical symptoms other than pain 51 “… all of a sudden I’ve had an urge to go to the toilet and before I’ve had a chance to 
turn around to walk towards the toilet, this just comes from me and it’s been really 
embarrassing”
Patient 032, female 25, recurrent stone former
“It’s like an irritation and if, you feel like you’re are bursting, but when you go, there’s 
hardly anything there”
Patient 003, male 49, recurrent stone former
Work and career 35 “You are worrying about when the next one is going to come, how that is going to 
impact on your future, like I am trying to progress in work now, go up the ladder in 
work”
Patient 065, female 39, recurrent stone former
Change in lifestyle or diet 46 “… my urine is always quite yellow, I am probably dehydrated quite a bit”
Patient 061, male 30, recurrent stone former
“I drink if I am thirsty you know if I am not thirsty I won’t just drink for the sake of 
drinking it, I don’t know maybe that’s the problem I’ve got maybe I should just drink 
anyway regardless but it’s hard for me to come and get a drink if I am not feeling 
thirsty”
Patient 021, male 46, recurrent stone former
Mental and emotional symptoms 40 “I am worried like as soon as I start getting like a little pain in my stomach I am pan-
icking that I am gonna have to go into hospital and I hate coming into hospital I like 
hate having to miss out on things my daughter does because I am stuck in hospital”
Patient 032, female 25, recurrent stone former
“… sometimes you are in bed and you can’t get out, but I make myself get out of bed 
and not think about what I am thinking and within 2 weeks it has gone!”
Patient 074, male 33, recurrent stone former
Social life 31 “… if you go for a walk in the country, you can’t really do that because you are drink-
ing water you have got to pee somewhere and that means you know there’s no toilets 
around, so it does restrict your activities”
Patient 033, female 49, recurrent stone former
“I feel lazy and tired and just isolated in a way and that is why I have kept myself 
away from so many people Hmm Which ain’t a good thing because they are my 
friends and I ain’t seeing them”
Patient 036, male 34, recurrent stone former
Difficulties with activities of daily living 25 “When you’re having a really bad attack there is nothing much you can do except sit 
down and feel sorry for yourself”
Patient 010, female 66, recurrent stone former
“So even shopping, shopping, didn’t do shopping on my own… food shopping 
because of lifting heavy bags so unfortunately my husband had to come and help 
out!”
Patient 017, female 54, non-recurrent stone former
Travel or holiday problems 19 “I didn’t want while I was going through treatment I didn’t want to have flare up while 
I was abroad and have to worry about you know picking up any type of infection or 
things we thought let’s get this sorted and then we can get back to how we were”
Patient 029, female 50, recurrent stone former
Relationships 13 “Yeah financially we suffered, and it put a big strain on our relationship like as well 
because we just couldn’t afford to keep our head above water…”
Patient 032, female 25, recurrent stone former
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be because stone patients tend to be of working age with 
economic dependents.
In terms of the groups ‘with’ or ‘without’ current stones, 
patients without current stones were less likely to suffer 
from, or have lower intensity of physical symptoms (as 
expected), but did have impact of the stones or interventions 
on psychosocial domains. Overall, we did not find major 
differences in the themes. This warrants more research in 
future, quantitative studies.
Other important HRQoL issues that we elicited were 
those pertaining to patients’ general outlook on life and 
mental and emotional symptoms. Patients reported the most 
difficult issues being the fact that there seemed to be no 
end in sight with their disease and the fear of the unknown 
that comes with having such a debilitating disease, where 
acute exacerbations can occur at any time in an unpredict-
able manner.
It is also important to note that in many, patients with uri-
nary stone disease tend to suffer on a chronic basis. Patients 
probably learn multiple coping mechanisms related to their 
stone disease and this will impact on the quantification of 
their quality of life—they may score the same quality-of-life 
issue more favourably after a period of time as their expec-
tations have been readjusted after living with the disease. 
Schwatrz et al. described this as ‘Response Shift Theory’ in 
2007 [26]. With this in mind, it would be useful to undertake 
longitudinal studies to evaluate the longer term impact of 
urinary stone disease.
The data gathered from the FROM-16© questionnaire 
showed that urinary stone disease had little impact on family 
members in either domain. This could be accounted by the 
fact that patients tend to be most anxious before a diagnosis 
is made and the family members that were approached after 
initial diagnosis. Administering the FROM-16© question-
naire to patients in the emergency department could give 
a clearer picture of what effect the patient’s disease has on 
their relative(s) in the acute setting.
When considering the treatment of urinary stone disease, 
extra attention should be given with respect to patient educa-
tion and quality of life. Patients with renal stones who are 
not experiencing an acute exacerbation may suffer slightly 
impaired quality of life (due to ‘niggling’ renal angle pain 
etc.), however, after treatment (ESWL, ureteroscopy), the 
HRQoL may deteriorate due to instrumentation/ureteric 
stone fragments. In this scenario, the HRQoL of the patient 
may be greatly impacted in the short term and may mimic 
the stone disease itself. Patients not warned of this prior to 
treatment may regret the decision to undergo any interven-
tion in the first place. Good patient communication and pre-
treatment counselling are the foundation of shared decision 
making and a studies has shown that good patient education 
may ameliorate ureteric stent-related symptom morbidity 
[27]. Patient education prior to urolithiasis interventions 
could similarly help as there is a wide variety of potential 
influences on patient choice.
Penniston et al. reported in 2012 that the most important 
factors impacting on quality of life of their stone population 
were patients’ concern about general health, pain, anxiety 
about current and future disease, decreased ability to focus 
on work, difficulty sleeping and lack of freedom to travel 
and attend social events. Many of these themes were con-
firmed to be similar to the ones identified in our population. 
However, in addition, we identified new findings related to 
the disease as well as the interventions and their complex 
interaction. Our study suggests that in our population sam-
ple, there were many other or related issues important to the 
patients. Similarly, we identified that the impact of current 
or past interventions, and indwelling stents can influence the 
intensity and the type of impact on different domains. We 
found that on many occasions, the impact tends to change 
during the treatment journey.
The most import HRQoL issues were pain, other physical 
symptoms, lack of support network, difficulty of disease pre-
vention, difficulties with work and career and anxiety about 
the future. The item generation process of this study was 
patient-centred with open-ended questions employed as to 
give the most accurate and in-depth view of what patients 
felt were their most important HRQoL issues.
Our study has limitations. The items generated from the 
study were produced from English-speaking patient popu-
lation in the United Kingdom. Patients from other coun-
tries and healthcare settings might have issues that were not 
picked up within our population. However, our response rate 
was excellent and therefore our data fairly represents the 
urinary stone formers within our population.
Difficulties were seen when attempting to disentangle 
HRQoL issues created from treatment from those associated 
with ureteric stent-related symptoms (a common adjunct 
used during the treatment of stone disease). All but the most 
veteran patients are unable to say which HRQoL issues were 
caused by ureteric stents and which were caused by the treat-
ment itself. A possible solution to this problem would be the 
use of a stent-specific outcome measure alongside the pro-
posed outcome measure when a stent (or stents) are deployed 
within the ureter [19].
Current methods of quantifying HRQoL in stone patients 
include the use of generic quality of life measures such as 
the SF-36 and EuroQol 5-Dimension (EQ-5D) [7]. New data 
have emerged from the disease-specific measures such as 
WISQOL and the use of PROMIS question banks. Many of 
the themes that were identified in our patient population have 
been identified as important QoL domains, as discussed ear-
lier in the discussion. Future data from the quantitative and 
interventional studies would help to confirm these findings.
The findings from the present study provide insights 
into aspects of HRQOL issues associated with the urinary 
Urolithiasis 
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stone disease and different treatments. It should be viewed 
as part of a fundamental shift in research from typical lim-
ited outcome studies, to a more patient-centred approach. 
It has formed the framework for our work on the new uni-
versal ‘Urinary Stone and Intervention Quality of Life 
measure’ (USI-QoL) patient-reported outcome measure. 
Similarly, it offers the basis for the development of patient-
centric measures such as patient-reported experience 
measures, decision aids and patient information tools.
Conclusion
We have exhaustively elicited the most important HRQoL 
issues faced by patients with urinary stone disease in our 
population. These data could help to form the framework 
for patient-centric measures and counselling tools for 
patients with urinary stone disease.
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